The global diabetes market is expected to grow at a CAGR of 7.6% percent for the forecasted period of 2018-2023. The market is segmented on the basis of the type of diabetes, drugs class, and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 8.9%. Some of the top-selling diabetic drugs include Lantus (Sanofi), Januvia (Merck And Co), Humalog (Eli Lily And Co), Novorapid (Novo Nordisk), Levemir (Novo Nordisk), Victoza (Novo Nordisk), Janumet (Merck And Co.), Novolog (Novo Nordisk), Humalin (Eli Lily And Co.) And Galvus (Novartis). With the diabetic population expected to cross the 350 million market by 2030 the market is expected to show a strong growth rate. Diabetic drugs are highly priced which could be one of the major drawbacks.



Get Free Sample Copy @

https://www.omrglobal.com/request-sample/diabetes-market



Diabetic devices include blood glucose meters and insulin delivery devices. The market for blood glucose meters will have the highest market share compared to the insulin delivery systems such as syringes and injection pens. Continuous glucose monitoring systems will have the highest market growth. Meter and strips are expected to dominate the overall market share in diabetic devices.



Browse for Full Report at:

https://www.omrglobal.com/industry-reports/diabetes-market



MARKET SEGMENTATION
DIABETES MARKET BY TYPE
TYPE 1 DIABETES
TYPE 2 DIABETES
GESTATIONAL

DIABETES MARKET BY DRUG CLASS
ALPHA-GLUCOSIDASE INHIBITORS
AMYLIN ANALOGS
ANTIDIABETIC COMBINATIONS
DIPEPTIDYL PEPTIDASE 4 INHIBITORS
INCRETIN MIMETICS
INSULIN
MEGLITINIDES
NON-SULFONYLUREAS
SGLT-2 INHIBITORS
SULFONYLUREAS
THIAZOLIDINEDIONE

DIABETES MARKET BY DEVICES
BLOOD GLUCOSE METERS
BLOOD GLUCOSE STRIPS
INSULIN INJECTION PENS
INSULIN SYRINGES
CONTINUOUS GLUCOSE MONITORING SYSTEMS
INSULIN PUMPS
LANCETS


COMPETITIVE LANDSCAPE
MARKET SHARE ANALYSIS
KEY COMPANY ANALYSIS


REGIONAL ANALYSIS
NORTH AMERICA
UNITED STATES
CANADA
REST OF NORTH AMERICA

EUROPE
UNITED KINGDOM
FRANCE
GERMANY
ITALY
SPAIN
REST OF EUROPE

ASIA PACIFIC
INDIA
CHINA
JAPAN

REST OF THE WORLD



COMPANY PROFILES

ABBOTT LABORATORIES INC
ALERE INC.
ASCENSIA DIABETES CARE
ASTRAZENECA LTD
BAYER AG
BECTON, DICKINSON AND COMPANY
BIOCON LTD.
BOEHRINGER INGELHEIM
BRISTOL-MYERS SQUIBB
CELLNOVO GROUP
DEXCOM INC
DIAMYD MEDICAL
ELI LILY AND CO.
F. HOFFMANN-LA ROCHE LTD.
GLAXOSMITHKLINE
GLENMARK
JOHNSON AND JOHNSON
JOSLIN DIABETES CENTER
LIFESCAN
LUPIN PHARMACEUTICALS LTD
MANNKIND CORPORATION
MEDTRONIC PLC
MERCK & CO.
MICRO LABS LTD
MSD PHARMACEUTICALS
NOVARTIS
NOVO-NORDISK
PFIZER
PROMETHEON PHARMA, LLC
SANOFI
SMITHS MEDICAL
SUN PHARMACEUTICALS INDUSTRIES LTD
TAKEDA PHARMACEUTICAL LTD.
TANDEM DIABETES CARE
THERMALIN, INC
USV PRIVATE LIMITED


Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.




For More Customized Data, Request for Report Customization @
https://www.omrglobal.com/report-customization/diabetes-market


About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404